Simply Wall St.
Assessing Arrowhead Pharmaceuticals (ARWR) Valuation After A Cooling Share Price And Strong Long-Term Returns
📊
AI Sentiment
Positive
6/10
Arrowhead Pharmaceuticals Inc. News
Latest updates and market news for ARWR
2 news
Feb 24 - Mar 2, 2026
Page 1
GlobeNewswire
Alpha-1 Antitrypsin Deficiency Research Report 2025-2035: Market Enters Growth Phase as Established Augmentation Therapies Converge with Advancing Gene and RNA Pipelines
📈
AI Sentiment
Highly Positive
8/10
Share this news page